Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 117 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Creatine Supplementation Clear all

Conditions: Cancer, Malignant Neoplasm
Interventions: Bioelectrical impedance Analysis (BIA), D3-Creatine Dilution (D3Cr), 6-Minute Walk Test (6MWT), Timed Up and Go (TUG), 30-second Sit-to-Stand (STS), Hand Grip Strength (GS), PBTL p16 expression, CT, MR and PET Imaging; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 8 Years to 21 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Central Serous Chorioretinopathy
Interventions: 25mg Eplerenone, Placebo; Drug
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 10
States / cities: Cherry Hill, New Jersey • Marlton, New Jersey • Mays Landing, New Jersey + 7 more

Conditions: Side Effects of Creatine Monohydrate Dosing
Interventions: Creatine Monohydrate; Other
Lead sponsor: Vireo Systems, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Raritan, New Jersey

Conditions: Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
Interventions: creatine monohydrate, placebo; Dietary Supplement · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2017
U.S. locations: 220
States / cities: Mobile, Alabama • Scottsdale, Arizona • Aurora, Colorado + 139 more

Conditions: Safety of Short Term Creatine Hydrochloride Dosing
Interventions: creatine supplementation; Dietary Supplement
Lead sponsor: Vireo Systems, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Raritan, New Jersey

Conditions: Bipolar I Disorder, Schizoaffective Disorder, Psychosis
Interventions: Ketogenic diet; Other
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 45 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Healthy
Interventions: Not listed
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Cancer, Breast Cancer Female, Muscle Weakness
Interventions: Creatine; Dietary Supplement
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Multiple Sclerosis
Interventions: Progressive exercise, Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV, Modified paleolithic diet, Omega 3 fatty acids, Full Spectrum vitamin, Essential - hydroxytyrosol, Maltodextrin fiber supplement, Mineral boost (magnesium), Niacinamide, Methyl B12, Taurine, creatine, thiamine, riboflavin, N acetylcysteine, alpha lipoic acid, L acetyl carnitine, methyl folate, coenzyme Q, meditation, self massage, learning, Coconut oil; Other · Device · Dietary Supplement + 1 more
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Ebola Virus Disease, Marburg Virus Disease
Interventions: cAd3-Marburg, cAd3-EBO-S; Biological
Lead sponsor: Albert B. Sabin Vaccine Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Colitis, Ulcerative
Interventions: Creatine monohydrate, Placebo; Drug · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Fatigue, Metastatic Prostate Carcinoma, Sedentary Lifestyle, Stage IV Prostate Cancer AJCC (American Joint Committee on Cancer) v8, Stage IVA Prostate Cancer AJCC (American Joint Committee on Cancer) v8, Stage IVB Prostate Cancer AJCC (American Joint Committee on Cancer) v8
Interventions: Creatine Monohydrate, Exercise Intervention, Questionnaire Administration; Dietary Supplement · Behavioral · Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Male only
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Cognitive Benefits
Interventions: Citicoline, Omega-3 Fatty Acids and Creatine; Drug
Lead sponsor: Deborah Yurgelun-Todd; Other
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Interventions: MB-102, Fludarabine, Cyclophosphamide; Biological · Drug
Lead sponsor: Mustang Bio; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 4
States / cities: Duarte, California • Boston, Massachusetts • Durham, North Carolina + 1 more

Conditions: Colorectal Cancer
Interventions: Resistance Exercise; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Breast Cancer, Chemotherapy Effect, Muscle Weakness, Muscle Loss, Exercise
Interventions: Creatine; Dietary Supplement
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Muscle Hypotrophy
Interventions: Carnipure AAS, Creatine Monohydrate; Dietary Supplement
Lead sponsor: Applied Science & Performance Institute; Industry
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: HIV Infections
Interventions: Use of creatine monohydrate (a dietary supplement), Progressive resistance exercise training; Procedure · Behavioral
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Idiopathic Inflammatory Myopathies
Interventions: electrical impedance myography, healthy control group; Device · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Major Depressive Disorder
Interventions: Creatine, Placebo; Drug
Lead sponsor: Perry Renshaw; Other
Eligibility: 12 Years to 21 Years · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Huntington's Disease
Interventions: Creatine; Drug
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 4
States / cities: Boston, Massachusetts • Long Island City, New York • New York, New York + 1 more

Conditions: Amyloidosis
Interventions: KIACTA (eprodisate disodium), Placebo; Drug
Lead sponsor: C.T. Development America, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 3
States / cities: Glendale, California • Boston, Massachusetts • Columbus, Ohio

Conditions: Proteinuria in Pregnancy
Interventions: Blood draw; Other
Lead sponsor: Marshall University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Huntington, West Virginia

Conditions: Huntington's Disease (HD)
Interventions: Creatine monohydrate; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Search by objective public record fields.

Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers

Eplerenone for the Treatment of Central Serous Chorioretinopathy

Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation

Creatine in Treating Patients With Cancer-Associated Weight Loss

Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study

Open Label Extension Study of NCT06221852

High-resolution Phosphocreatine and Creatine Mapping of Human Muscle and Brain

THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

Citicoline, Creatine, and Omega-3 Effects in Middle Age Women

Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.

Resistance Exercise and Creatine in Colorectal Cancer

Effects of Creatine Supplementation in Breast Cancer Survivors

Assessment of the Efficacy of Carnipure® AAS on Body Composition, Muscle Thickness, and Strength Adaptations in Healthy Men

Effects of Creatine and Resistance Exercise Training in People With HIV Infection

Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies

Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder

Creatine Therapy for Huntington's Disease

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

The Effect of Blood on the PC Ratio During Pregnancy

Creatine Safety & Tolerability in Huntington's Disease